Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jan;26(1):10-20.
doi: 10.1007/s11912-023-01472-8. Epub 2023 Dec 15.

Racial Disparities in Breast Cancer: from Detection to Treatment

J C Chen  1 , Daniel G Stover  2 , Tarah J Ballinger  3 , Jose G Bazan  4 , Bryan P Schneider  3 , Barbara L Andersen  5 , William E Carson  1 , Samilia Obeng-Gyasi  6   7
Affiliations
Review

Racial Disparities in Breast Cancer: from Detection to Treatment

J C Chen et al. Curr Oncol Rep. 2024 Jan.

Abstract

Purpose of review: Update on current racial disparities in the detection and treatment of breast cancer.

Recent findings: Breast cancer remains the leading cause of cancer death among Black and Hispanic women. Mammography rates among Black and Hispanic women have surpassed those among White women, with studies now advocating for earlier initiation of breast cancer screening in Black women. Black, Hispanic, Asian, and American Indian and Alaskan Native women continue to experience delays in diagnosis and time to treatment. Further, racial discrepancies in receipt of guideline-concordant care, access to genetic testing and surgical reconstruction persist. Disparities in the initiation, completion, toxicity, and efficacy of chemotherapy, endocrine therapy, and targeted drug therapy remain for racially marginalized women. Efforts to evaluate the impact of race and ethnicity across the breast cancer spectrum are increasing, but knowledge gaps remain and further research is necessary to reduce the disparity gap.

Keywords: Breast cancer; Detection; Health inequities; Race; Treatment.

PubMed Disclaimer

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
    1. • Giaquinto AN, Sung H, Miller KD, Kramer JL, Newman LA, Minihan A, et al. Breast Cancer Statistics, 2022. CA Cancer J Clin. 2022;72(6):524–41. https://doi.org/10.3322/caac.21754 . American Cancer Society’s most recent update on breast cancer statistics including incidence, screening behaviors, mortality, and survival. - DOI - PubMed
    1. Giaquinto AN, Miller KD, Tossas KY, Winn RA, Jemal A, Siegel RL. Cancer statistics for African American/Black People 2022. CA Cancer J Clin. 2022;72(3):202–29. https://doi.org/10.3322/caac.21718 . - DOI - PubMed
    1. Duffy SW, Tabár L, Yen AM, Dean PB, Smith RA, Jonsson H, et al. Mammography screening reduces rates of advanced and fatal breast cancers: results in 549,091 women. Cancer. 2020;126(13):2971–9. https://doi.org/10.1002/cncr.32859 . - DOI - PubMed
    1. Ahmed AT, Welch BT, Brinjikji W, Farah WH, Henrichsen TL, Murad MH, et al. Racial disparities in screening mammography in the United States: a systematic review and meta-analysis. J Am Coll Radiol. 2017;14(2):157-65.e9. https://doi.org/10.1016/j.jacr.2016.07.034 . - DOI - PubMed
    1. Hensing WL, Poplack SP, Herman CR, Sutcliffe S, Colditz GA, Ademuyiwa FO. Racial differences in no-show rates for screening mammography. Cancer. 2021;127(11):1857–63. https://doi.org/10.1002/cncr.33435 . - DOI - PubMed

LinkOut - more resources